CN1706474A - Chinese medicine composition for treating hepatitis B and viral hepatitis - Google Patents
Chinese medicine composition for treating hepatitis B and viral hepatitis Download PDFInfo
- Publication number
- CN1706474A CN1706474A CN 200510049895 CN200510049895A CN1706474A CN 1706474 A CN1706474 A CN 1706474A CN 200510049895 CN200510049895 CN 200510049895 CN 200510049895 A CN200510049895 A CN 200510049895A CN 1706474 A CN1706474 A CN 1706474A
- Authority
- CN
- China
- Prior art keywords
- radix
- hepatitis
- herba
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine composition for treating hepatitis B and viral hepatitis is prepared with oldenlandia 1-30 weight portions, sun plant 1-30 weight portions, flavescent sophora root 1-30 weight portions, tonkin sophora root 1-20 weight portions, astragalus root 1-30 weight portions, curcuma root 1-22 weight portions and bupleurum root 1-20 weight portions. It has obvious treating effect, and low cost.
Description
One, affiliated technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of hepatitis, refer in particular to a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis.
Two, background technology
Viral hepatitis is the infectious disease that is caused the liver inflammation by some viruses.The kind of viral hepatitis has first type, B-mode, third type and hepatitis E.And by other rarer viral hepatitis kinds have the fourth type and heptan type.First type and hepatitis E are via contaminated water and food (as the shell marine products) and infect.But hepatitis B do as one likes contact, infect with the shared syringe of carrier, the viruliferous blood of input or blood manufactured goods, also can pass to the baby to virus during malicious in spite of illness mother's what farrowing interval or the what infancy, other route of infection be included in and tatoo, pierce one's ears or acupuncture-moxibustion in use contaminated instrument.The above-mentioned route of infection all are via the contact of blood or body fluid and be infected by the virus.In China, about 10% population is the hepatitis B carrier, and these carriers have higher chance to suffer from chronic hepatitis, liver cirrhosis and hepatocarcinoma.The route of infection of hepatitis C comprise input viruliferous blood or blood manufactured goods, contact or shared syringe with the infected is sexual.Hepatitis C carrier also can increase the chance of suffering from liver cirrhosis or hepatocarcinoma.Therefore, development is a kind ofly specially controlled hepatitis B, the viral hepatitis special effect Chinese is very significant.Chinese patent once disclosed " a kind of Chinese medicine pill for the treatment of hepatitis B " (application number: 931086175, publication number: CN1083723A, open day: on March 16th, 1994), contain Radix Notoginseng, ant, the Radix Astragali, Polyporus, give birth to army, Indigo Naturalis, Herba Duchesneae Indicae, Herba Solani Nigri and pull out chinaroot greenbrier.
Three, summary of the invention
The object of the present invention is to provide a kind of therapeutic effect remarkable, the medicine source is extensive, treatment hepatitis B with low cost, the Chinese medicine composition of viral hepatitis.
For achieving the above object, the solution that the present invention takes is: a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis, it is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20.
Among the present invention: the immunity of Herba Hedyotidis Diffusae energy enhancing body, stimulate reticuloendothelial cell hyperplasia, strengthen the phagocyte vigor.Zoopery confirms that behind Herba Hedyotidis Diffusae, visible skein cell hypertrophy is very active, skein cell glandular hyperplasia hypertrophy, endochylema is abundant, engulfs active, Herba Hedyotidis Diffusae can also strengthen the ability of leukocytes phagocytic cell, strengthens the effect and the hepatoprotective effect of serum sterilizing.Herba Hedyotidis Diffusae contains oleanolic acid, can reduce the rising of the glutamate pyruvate transaminase of laboratory animal hepatic injury, alleviate the inflammatory reaction and the fibrotic processes of hepatocellular degeneration, necrosis and hepatic tissue, promote liver cell regeneration, quicken the reparation of slough, have antitumor action.Herba Hedyotidis Diffusae is woven with inhibitory action to white mice ascites tumor group, tumor in the white mice 180 there is inhibitory action, the karyokinesis of cancerous cell is resembled be subjected to remarkable inhibition, cancerous tissue degeneration necrosis degree alleviates, its contained triterpene acids is to lymph tumor I ascitic type cervical cancer 14 liver substance types and polysaccharide, to lymph tumor I ascitic type, Emhorn ascites hypodermic type all has remarkable inhibitory action.The Henan medical college finds that Herba Hedyotidis Diffusae has stronger inhibitory action to hbs antigen HBSAG in the drug screening process.
The Radix Astragali has significant promotion back regulating action to immunologic function, can strengthen the phagocytic function of reticuloendothelial system, increase metabolism, motion and the phagocytic function of macrophage, the function that promotes that human lymphocyte transforms is arranged, the effect of inducement interferon is arranged, and interference have the effect that suppresses sick plain breeding, the effect of adjusting adenosine cyclophosphate (CAMP) and cycli phosphate crow glycosides (CGMP) is arranged, and an amount of adenosine cyclophosphate has the effect that adds powerful antibody and interferon, make in addition that leukocyte significantly increases in the blood, the effect that the leukocytes phagocytic index rises.The Radix Astragali has hepatoprotective effect to the zoopery liver damage due to carbon tetrachloride or the thioacetamide, can make hepatic glycogen increase lysosome and organize dehydrogenase active.The Radix Astragali can improve body nonspecific immunity, humoral immunization, cellular immune function, improves the activity of natural killer cell, promotes inducement interferon, can reduce erythrocyte immune and stick the inhibitive factor activity, improves the activity of enhancer.Radix Astragali energy enhancing human body immunity power function can compare favourably in vain with third kind of Placenta Hominis ball, and anti-aging effects is arranged, can prevent senile arteriosclerosis, improve pulmonary function, improve the activity of oxide dismutase, animal blood glucose there is dual regulation, but islets of langerhans disposition hypoglycemia is not had obvious influence.Contained total flavones total saponins total polysaccharides has the effect of removing oxygen-derived free radicals to xanthine/xanthine oxidase system; can increase anemia person's erythrocyte and hemoglobin; promote leukocytic thrombocytopenia person to recover normal; and can improve or recover erythrocytic function; myocardial cell there is protective effect, can obviously improves viral myocarditis patient cardiac status.Zoopery shows that the Radix Astragali has certain antitumaous effect, can reduce the cancer incidence rate, prolongs survival period, and diuresis is arranged, and can reduce urine albumen amount, alleviates nephropathy.
Radix Sophorae Tonkinensis has hepatoprotective effect.In zoopery, the Hepar Mus tissue injury of carbon tetrachloride poisoning is alleviated and the face that inclines of significantly repairing is again arranged, obtain through refining the fluid injection effect of reducing enzyme levels of forging a good relationship, general medication 2-4 week ALT can reduce to normally, improve serum albumin in addition, reduce the globulin effect, and the energy raise immunity, turning out cloudy of DNAP and NBEAG also there is certain effect.The extract matrine all has inhibitory action to group B streptococcus, staphylococcus aureus, dysentery bacterium, escherichia coli.
Radix Sophorae Flavescentis can antiviral.Adopt heavily to have to propagate and infect the positive sheldrake modeling of DHBV, matrine has better action to B virus, Radix Sophorae Flavescentis extracts alkaloid has certain effect of reducing enzyme levels to rat carbon tetrachloride poisoning hepatitis, and pathologic finding finds that the large stretch of necrosis of hepatocyte can reduce because of its increase for the treatment of dose.
Herba Scutellariae Barbatae has slight inhibitory action to acute granulocyte type leukemia, decoct has inhibitory action to staphylococcus aureus, shigella flexneri, Bacillus typhi, bacillus pyocyaneus, escherichia coli, contained Flos Carthami have the smooth muscle spasm effect that stronger antagonism is caused by histamine, and good phlegm-dispelling functions is arranged.
Radix Curcumae has the metabolic effect of pair hepatic glycogen.Radix Curcumae volatile oil is made 0.5% injection has the synthetic and inhibition hepatic glycogen decomposition of the hepatic glycogen of promotion to the rat injection, to the effect of protein metabolism.Radix Curcumae volatile oil can promote synthetic albumin α of rat hepatocytes and beta Globulin, suppresses the synthetic of gamma Globulin, also reduces the content of plasma fibrinogen simultaneously, to the effect of lipid metabolism.Turmeric powder 134mg/100g gives the experimental atherosclerosis rat, and serum cholesterol and C/P value are slight to raise, but can suppress in the aortic tunica intima that atheromatous plaque forms and lipid heavy with.The volatile oil injection then makes experimental hyperlipidemia rat blood serum cholesterol and beta Lipoprotein content reduce and corrects α-and the ratio row imbalance of beta lipoprotein, and aorta cholesterol and diacylglycerol content are reduced.Volatile oil has blood fat reducing and study of anti-atherogenic effect.The Radix Curcumae decoct activates cholesterol 7 for the oral activity that can obviously suppress the auxiliary A reductase (HINGR) of hepatocyte microsome 3-hydroxyl 3-methyl glutaryl of rat, experiment in vitro 4mg/g Radix Curcumae decoct has same direct repression to isolated rat hepatocyte HMGR, its action intensity and N α F (50mmo '/l) close, its mechanism of action is for Profilin phosphatase reversibly and activate the kinase whose activity of HMGR, HMGR is the synthetic key enzyme of cholesterol, the synthetic minimizing of cholesterol when being suppressed, 7 α-hydroxylase are that to make cholesterol 7 α position hydroxylations be 7 α-hydroxylase.This is the first step that cholesterol changes bile acid into, the liver synthetic bile acid then is to raise from 7 α-hydroxylase activity that new synthetic non-fat cholesterol is a precursor, can promote that cholesterol changes bile into, 7 α-hydroxylase also has inhibitory action through cholesterol to HMGR simultaneously.These effects of Radix Curcumae help reducing the level of cholesterolemia.The extract of Radix Curcumae has significant protective effect to the hepatic injury that carbon tetrachloride causes, can reduce SGPT, improves the blood plasma total protein; promote albuminous synthesizing, suppress the generation of gamma Globulin, and can make impaired hepatocellular three mitochondrions and coarse net face endoplasm recover normal; thereby has hepatoprotective effect
That Radix Bupleuri has is significantly analgesic, calm, convulsion, analgesia and antitussive effect.The antiinflammatory intensity of saikoside is similar to prednisone, and anti-granuloma hypertrophy is stronger than exudation effect, and effects such as hepatic cholagogic, anti-gastric-ulcer are arranged, and effect for reducing blood fat is arranged, and is more obvious than cholesterol to the triglyceride effect.The Radix Bupleuri polysaccharide has potentiation to immunity of body liquid and cellular immune function, and can increase the protein biosynthesis of rat.With saikoside α lumbar injection or oral, tumor S180, P388 and ehrlich ascites cell in the mice transplanting all are obvious inhibitory action.Decoct has certain inhibitory action to Hemolytic streptococcus, vibrio cholera, tubercule bacillus and leptospira, and influenza virus, epidemic haemorrhagic fever virus are also had inhibitory action.
As improvement, Chinese medicine composition of the present invention is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30.
As further improvement, Chinese medicine composition of the present invention is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30.
As step improvement again, Chinese medicine composition of the present invention is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30, Fructus Schisandrae Chinensis 1-20.
As better improvement, Chinese medicine composition of the present invention is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30, Fructus Schisandrae Chinensis 1-20, Fructus Forsythiae 1-30.
As preferably, Chinese medicine composition of the present invention is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30, Fructus Schisandrae Chinensis 1-20, Fructus Forsythiae 1-30, Herba Peristrophes 1-30.
As further preferred, Chinese medicine composition of the present invention is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30, Fructus Schisandrae Chinensis 1-20, Fructus Forsythiae 1-30, Herba Peristrophes 1-30, Herba Sedi 1-30.
Herb Gynostemmae Pentaphylli, Radix Isatidis, Fructus Schisandrae Chinensis, Fructus Forsythiae, Herba Peristrophes, Herba Sedi all have the effect of clearing away heat-damp and promoting diuresis, depressed liver-energy dispersing and function of gallbladder promoting.
The present invention with reference to the modern pharmacological research achievement, with clinical use makes treatment hepatitis specific drug through research for many years based on secret prescription handed down in the family from generation to generation.Said herbal medicine forms through scientific compatibility, cure mainly the hepatitis disease (popular name: ascites hepatitis, food stagnation hepatitis, jaundice hepatitis) of the caused acute icteric infectious hepatitis of various hepatitis viruss, type b chronic non-icteric type infectious hepatitis etc. and other type, be used in particular for treating hepatitis B and viral hepatitis, its therapeutic effect is remarkable, the medicine source is extensive, and is with low cost.
The Chinese herbal medicine porphyrize of above-mentioned compatibility is sieved after by scientific process is carried out packing, every bag (bag) 35 gram, every bag of (bag) child divides and takes for six times, and the adult divides four times, divides every day after meal, secondary is swallowed with eliminating cold for resuscitation water after the supper morning.
Period in a medicine is forbidden diet acid, peppery, cigarette, wine, chicken, Oryza glutinosa, dried small shrimps and stodgy rice cake rice cake etc. and dry weight physical work, avoids clothes Folium Camelliae sinensis, Semen Glycines, fresh hen egg, preserved egg, river Eriocheir sinensis, tonic, Erythroculter ilishaeformis, Semen Phaseoli radiati Germinatus etc.
Clinical case statistics through system, effective more than 90% to the treatment acute icterohepatitis, now be exemplified below:
One: one 30 years old male patient of case, loss of appetite, gastral cavity side of body distension, spiritlessness and weakness, whole skin xanthochromia, 39 ℃ of body temperature, through biochemical investigation: glutamate pyruvate transaminase 395, GOT2 70, globulin 37, total bilirubin 49.4, bilirubin direct 27, two double, hepatitis b surface antigen positive 1: 512, the e antibody positive, core antibody positive.Through western medical treatment 20 days, every day, total bilirubin raise, and curative effect is little, through biochemical investigation: glutamate pyruvate transaminase 459, GOT2 27, globulin 39.4, total bilirubin 237.4, bilirubin direct 171.1, hepatitis b surface antigen positive 1: 256, e antibody positive, core antibody positive.Through 20 days clothes Drug therapy of the present invention, liver function test list: glutamate pyruvate transaminase 37, GOT2 8, total bilirubin 59, bilirubin direct 43, hepatitis b surface antigen positive 1: 64, e antibody positive, core antibody positive.Through 20 days medication treatment, liver function recovery was normal again, and two double, hepatitis b surface antigen positive 1: 16, e antibody positive, core antibody positive.Continue treatment half a year, liver function is normal, two double normal, follow up a case by regular visits to and do not see recurrence in 2 years.
Two: one 56 years old female patients of case are through biochemical investigation: total bilirubin 25.7, bilirubin direct 14.9, TOTAL BILE ACID TBA 24, total protein 87.8, globulin 50.8, Archon is than 0.7, prealbumin 11.8, glutamate pyruvate transaminase 79.5, glutamic oxaloacetic transaminase, GOT 87.0, G paddy hydrogen acyltransferase 125.9, alpha-fetoprotein 833.7, e antigen positive, the e antibody positive, core antibody positive.Through 1 month clothes Drug therapy of the present invention, liver function is normal, alpha-fetoprotein 279, two double e antigen, e antibody, core antibody positive.Through the medication treatment of half a year, alpha-fetoprotein is normal again, two double normal, follow up a case by regular visits to and do not see recurrence in 3 years.
Three: one 45 years old male patients of case have the hepatitis B great three positive medical history in 5 years, and through the clothes in 1 year Drug therapy of the present invention, it is normal that great three positive recovers, and follows up a case by regular visits to and do not see recurrence in 10 years.
Four: one 32 years old female patients of case have the hepatitis B great three positive medical history in 5 years, and through the clothes in 1 year Drug therapy of the present invention, it is normal that great three positive recovers, and follows up a case by regular visits to and do not see recurrence in 7 years.
Four, the specific embodiment
Embodiment one: a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis, (unit: gram) raw material is formed: Herba Hedyotidis Diffusae 20, Herba Scutellariae Barbatae 20, Radix Sophorae Flavescentis 20, Radix Sophorae Tonkinensis 10, the Radix Astragali 20, Radix Curcumae 12, Radix Bupleuri 10 by following each raw material for it.
Embodiment two: a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis, (unit: gram) raw material is formed: Herba Hedyotidis Diffusae 20, Herba Scutellariae Barbatae 20, Radix Sophorae Flavescentis 20, Radix Sophorae Tonkinensis 10, the Radix Astragali 20, Radix Curcumae 12, Radix Bupleuri 10, Herb Gynostemmae Pentaphylli 20 by following each raw material for it.
Embodiment three: a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis, and (unit: gram) raw material is formed: Herba Hedyotidis Diffusae 20, Herba Scutellariae Barbatae 20, Radix Sophorae Flavescentis 20 by following each raw material for it, Radix Sophorae Tonkinensis 10, the Radix Astragali 20, Radix Curcumae 12, Radix Bupleuri 10, Herb Gynostemmae Pentaphylli 20, Radix Isatidis 20.
Embodiment four: a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis, and (unit: gram) raw material is formed: Herba Hedyotidis Diffusae 20, Herba Scutellariae Barbatae 20, Radix Sophorae Flavescentis 20 by following each raw material for it, Radix Sophorae Tonkinensis 10, the Radix Astragali 20, Radix Curcumae 12, Radix Bupleuri 10, Herb Gynostemmae Pentaphylli 20, Radix Isatidis 20, Fructus Schisandrae Chinensis 10.
Embodiment five: a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis, (unit: gram) raw material is formed: Herba Hedyotidis Diffusae 20, Herba Scutellariae Barbatae 20, Radix Sophorae Flavescentis 20 by following each raw material for it, Radix Sophorae Tonkinensis 10, the Radix Astragali 20, Radix Curcumae 12, Radix Bupleuri 10, Herb Gynostemmae Pentaphylli 20, Radix Isatidis 20, Fructus Schisandrae Chinensis 10, Fructus Forsythiae 20.
Embodiment six: a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis, and (unit: gram) raw material is formed: Herba Hedyotidis Diffusae 20, Herba Scutellariae Barbatae 20 by following each raw material for it, Radix Sophorae Flavescentis 20, Radix Sophorae Tonkinensis 10, the Radix Astragali 20, Radix Curcumae 12, Radix Bupleuri 10, Herb Gynostemmae Pentaphylli 20, Radix Isatidis 20, Fructus Schisandrae Chinensis 10, Fructus Forsythiae 20, Herba Peristrophes 20.
Embodiment seven: a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis, and (unit: gram) raw material is formed: Herba Hedyotidis Diffusae 20, Herba Scutellariae Barbatae 20 by following each raw material for it, Radix Sophorae Flavescentis 20, Radix Sophorae Tonkinensis 10, the Radix Astragali 20, Radix Curcumae 12, Radix Bupleuri 10, Herb Gynostemmae Pentaphylli 20, Radix Isatidis 20, Fructus Schisandrae Chinensis 10, Fructus Forsythiae 20, Herba Peristrophes 20, Herba Sedi 20.
Claims (7)
1, a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis, it is characterized in that: it is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20.
2, a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis according to claim 1, it is characterized in that: it is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30.
3, a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis according to claim 1, it is characterized in that: it is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30.
4, a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis according to claim 1, it is characterized in that: it is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30, Fructus Schisandrae Chinensis 1-20.
5, a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis according to claim 1, it is characterized in that: it is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30, Fructus Schisandrae Chinensis 1-20, Fructus Forsythiae 1-30.
6, a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis according to claim 1, it is characterized in that: it is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30, Fructus Schisandrae Chinensis 1-20, Fructus Forsythiae 1-30, Herba Peristrophes 1-30.
7, a kind of Chinese medicine composition for the treatment of hepatitis B, viral hepatitis according to claim 1, it is characterized in that: it is made up of the following weight proportion raw material: Herba Hedyotidis Diffusae 1-30, Herba Scutellariae Barbatae 1-30, Radix Sophorae Flavescentis 1-30, Radix Sophorae Tonkinensis 1-20, Radix Astragali 1-30, Radix Curcumae 1-22, Radix Bupleuri 1-20, Herb Gynostemmae Pentaphylli 1-30, Radix Isatidis 1-30, Fructus Schisandrae Chinensis 1-20, Fructus Forsythiae 1-30, Herba Peristrophes 1-30, Herba Sedi 1-30.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100498959A CN100460010C (en) | 2005-05-29 | 2005-05-29 | Chinese medicine composition for treating hepatitis B and viral hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100498959A CN100460010C (en) | 2005-05-29 | 2005-05-29 | Chinese medicine composition for treating hepatitis B and viral hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1706474A true CN1706474A (en) | 2005-12-14 |
| CN100460010C CN100460010C (en) | 2009-02-11 |
Family
ID=35580706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100498959A Expired - Fee Related CN100460010C (en) | 2005-05-29 | 2005-05-29 | Chinese medicine composition for treating hepatitis B and viral hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100460010C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103830563A (en) * | 2014-03-05 | 2014-06-04 | 上海中医药大学附属曙光医院 | Traditional Chinese medicine composition for treating chronic hepatitis c |
| CN105560861A (en) * | 2016-01-14 | 2016-05-11 | 徐昌霞 | Traditional Chinese medicine for treating viral hepatitis |
| WO2017181816A1 (en) * | 2016-04-21 | 2017-10-26 | 广东省中医院 | Pharmaceutical composition for treating hepatitis, liver fibrosis and liver cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066628C (en) * | 1996-02-15 | 2001-06-06 | 邵阳县中医院 | Medicine for chronic hepatitis B and its preparation |
| CN1190229C (en) * | 2003-02-12 | 2005-02-23 | 朱培田 | Medicine for curing hepatitis B |
| CN1241591C (en) * | 2003-06-20 | 2006-02-15 | 周大勇 | Taiyi liver protection capsule and its preparing method |
-
2005
- 2005-05-29 CN CNB2005100498959A patent/CN100460010C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103830563A (en) * | 2014-03-05 | 2014-06-04 | 上海中医药大学附属曙光医院 | Traditional Chinese medicine composition for treating chronic hepatitis c |
| CN103830563B (en) * | 2014-03-05 | 2016-06-15 | 上海中医药大学附属曙光医院 | The Chinese medicine composition of preventing and treating chronic hepatitis C and application thereof |
| CN105560861A (en) * | 2016-01-14 | 2016-05-11 | 徐昌霞 | Traditional Chinese medicine for treating viral hepatitis |
| WO2017181816A1 (en) * | 2016-04-21 | 2017-10-26 | 广东省中医院 | Pharmaceutical composition for treating hepatitis, liver fibrosis and liver cancer |
| CN107303300A (en) * | 2016-04-21 | 2017-10-31 | 广州中医药大学第二附属医院 | Treat the drug regimen of hepatitis, liver fibrosis and liver cancer |
| US10729713B2 (en) | 2016-04-21 | 2020-08-04 | Guangdong Provincial Hospital Of Chinese Medicine | Pharmaceutical composition for treating hepatitis, liver fibrosis, and liver cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100460010C (en) | 2009-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101357219A (en) | Medicine for treating chronic hepatitis b | |
| CN102697035A (en) | Cordyceps anti-aging pellet | |
| CN100460010C (en) | Chinese medicine composition for treating hepatitis B and viral hepatitis | |
| CN101947296A (en) | Chinese medicine composition for treating diabetes | |
| CN102551058A (en) | Chinese medicinal health-care product with function of enhancing immunity | |
| CN101186627B (en) | Method for preparing picroside I | |
| CN106668811A (en) | Lycium ruthenicum anticancer lifesaving tablets | |
| CN1720974A (en) | Chinese medicinal composition for treating ascites due to cirrhosis | |
| CN103340991B (en) | Oral liquid for nursing diabetics and preparation method thereof | |
| CN103169838B (en) | Medicine for treating hepatitis B | |
| CN112516276A (en) | Traditional Chinese medicine for preventing novel coronavirus pneumonia, preparation process thereof and traditional Chinese medicine beverage | |
| CN101874858B (en) | Traditional Chinese medicine for treating virus hepatitis and preparation method thereof | |
| CN1596710A (en) | Melissa powder honeyed pill and its preparation method | |
| CN104644683A (en) | American cockroach chewable tablet, preparation method and use | |
| CN102397430B (en) | Cinobufotalin liver nourishing capsules | |
| TWI258373B (en) | Auxiliary agent for hepatitis C | |
| CN115300572B (en) | A Chinese medicinal composition for treating male infertility, and its preparation method and a beverage for treating male infertility | |
| CN100528209C (en) | Preparation method of traditional Chinese medicine preparation having functions of invigorating qi and yin and blood and releasing poison | |
| CN103041260B (en) | Chinese medicinal composition for treating acquired immune deficiency syndrome (AIDS) and preparation process | |
| CN1116069C (en) | Health care oral liquid for old people and preparation process thereof | |
| CN1176673C (en) | Compound and powder prescription | |
| CN1488372A (en) | Chinese medicine formual for treating heptitis | |
| CN114788859A (en) | Steam equipment multi-vitamin for adjuvant therapy of Acquired Immune Deficiency Syndrome (AIDS), and preparation method and application thereof | |
| CN1931239B (en) | Chinese medicine prepn for treating hepatitis B | |
| CN102631489B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090211 Termination date: 20130529 |